Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Avoiding Physician Liability for Off-Label Use of Drugs and Devices

By Lori G. Cohen and Sara K. Thompson
November 29, 2010

This month, we continue our discussion with an anlysis of attacks on the physician's decision to prescribe off-label.

Generally, the most common potential liability for off-label prescriptions will be a malpractice or negligence claim, in which the patient attacks the physician's decision, in her medical judgment, that a particular off-label use was appropriate for a particular patient. See Paul D. Rheingold & David B. Rheingold, Offense or Defense? Managing the Off-Label Use Claim, 37 Trial, Mar. 2001, at 52-55. The threat of malpractice liability effectively limits physicians' considerations of more obscure or extreme off-label uses for drugs and devices, because the physician must still show that the off-label use was an appropriate exercise of medical judgment given the information available to him or her at the time. In order to prevail on a malpractice or negligence claim in this scenario, the patient will be required to show that the physician's decision to use the drug or device in that manner failed to comport with “the skill and knowledge normally possessed by members of [the medical] profession ' in good standing in similar communities.” Restatement (Second) of Torts ' 299A (1965). The applicable standard of care is usually interpreted to be a national standard rather than local. See, e.g., Logan v. Greenwich Hospital Ass'n, 465 A.2d 294, 301 (Conn. 1983) (noting that many states have abandoned locality restrictions in favor of a national standard of care).

Read These Next
The DOJ's Corporate Enforcement Policy: One Year Later Image

The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.

The DOJ's New Parameters for Evaluating Corporate Compliance Programs Image

The parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.

Use of Deferred Prosecution Agreements In White Collar Investigations Image

This article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.

Bankruptcy Sales: Finding a Diamond In the Rough Image

There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.

A Lawyer's System for Active Reading Image

Active reading comprises many daily tasks lawyers engage in, including highlighting, annotating, note taking, comparing and searching texts. It demands more than flipping or turning pages.